Professor Dave Wright
Professor
D.Wright2@exeter.ac.uk
+44 7713 088402
Knowledge Spa
University of Exeter Medical School, Knowledge Spa, Royal Cornwall Hospital, Truro, TR1 3HD
Publications
Journal articles
Caswell R, Snowsill T, Houghton J, Chakera A, Shepherd M, Laver T, Knight BA, Hattersley AT, Ellard S (In Press). Non-invasive fetal genotyping by droplet digital PCR to identify maternally-inherited monogenic diabetes variants. Clinical Chemistry
Wright D, Nicolaides KH (2024). Aspirin for those at high risk: When to stop?. BJOG, 131(4). Author URL.
Wright D, Wright A, Magee LA, Von Dadelszen P, Nicolaides KH (2024). Calcium supplementation for the prevention of pre-eclampsia: Challenging the evidence from meta-analyses. BJOG Abstract. Author URL.
Wright A, Wright D, Chaveeva P, Molina FS, Akolekar R, Syngelaki A, Petersen OB, Kristensen SE, Nicolaides KH (2024). Fetal Medicine Foundation charts for fetal growth in twins. Ultrasound Obstet Gynecol, 63(2), 181-188. Abstract. Author URL.
Nicolaides KH, Syngelaki A, Poon LC, Rolnik DL, Tan MY, Wright A, Wright D (2024). First-trimester prediction of preterm pre-eclampsia and prophylaxis by aspirin: Effect on spontaneous and iatrogenic preterm birth. BJOG, 131(4), 483-492. Abstract. Author URL.
Wright D, Wright A, Rehal A, Syngelaki A, Kristensen SE, Petersen OB, Nicolaides KH (2024). Incidence of neonatal morbidity in small-for-gestational-age twins based on singleton and twin charts. Ultrasound Obstet Gynecol, 63(3), 365-370. Abstract. Author URL.
Rolnik DL, Syngelaki A, O'Gorman N, Wright D, Poon LC, Nicolaides KH (2023). ASPRE trial: effects of aspirin on mean arterial blood pressure and uterine artery pulsatility index trajectories in pregnancy. Ultrasound Obstet Gynecol, 61(6), 691-697. Abstract. Author URL.
Rolnik DL, Syngelaki A, O'Gorman N, Wright D, Nicolaides KH, Poon LC (2023). Aspirin for evidence-based preeclampsia prevention trial: effects of aspirin on maternal serum pregnancy-associated plasma protein a and placental growth factor trajectories in pregnancy. Am J Obstet Gynecol Abstract. Author URL.
Kristensen SE, Gadsbøll K, Nicolaides KH, Vogel I, Pedersen LH, Wright A, Petersen OB, Wright D (2023). Atypicality index: avoiding false reassurance in prenatal screening. Ultrasound Obstet Gynecol, 61(3), 333-338. Abstract. Author URL.
Nicolaides KH, Wright D (2023). Authors' reply. BJOG, 130(7). Author URL.
Rolnik DL, Syngelaki A, O'Gorman N, Wright D, Nicolaides K, Poon LC (2023). EP18.03: ASPRE trial: effects of aspirin on serum PAPP‐A and PlGF trajectories in pregnancy. Ultrasound in Obstetrics and Gynecology, 62(S1), 206-206.
Wright A, von Dadelszen P, Magee LA, Syngelaki A, Akolekar R, Wright D, Nicolaides KH (2023). Effect of race on the measurement of angiogenic factors for prediction and diagnosis of pre-eclampsia. BJOG, 130(1), 78-87. Abstract. Author URL.
Rolnik DL, Syngelaki A, O'Gorman N, Wright D, Poon LC, Nicolaides K (2023). OC19.05: ASPRE trial: effects of aspirin on mean arterial blood pressure and uterine artery pulsatility index trajectories in pregnancy. Ultrasound in Obstetrics and Gynecology, 62(S1), 45-45.
von Dadelszen P, Syngelaki A, Wright A, Akolekar R, Magee L, Wright D, Nicolaides K (2023). OP09_2. The implications of the fetal medicine foundation 35-36 week preeclampsia prediction competing risk model on timing of birth. Pregnancy Hypertension, 33, e71-e72.
Papastefanou I, Wright D, Syngelaki A, Akolekar R, Nicolaides KH (2023). Personalized stratification of pregnancy care for small for gestational age neonates from biophysical markers at midgestation. Am J Obstet Gynecol, 229(1), 57.e1-57.e14. Abstract. Author URL.
Riishede I, Rode L, Sperling L, Overgaard M, Ravn JD, Sandager P, Skov H, Wagner SR, Nørgaard P, Clausen TD, et al (2023). Pre-eclampsia screening in Denmark (PRESIDE): national validation study. Ultrasound Obstet Gynecol, 61(6), 682-690. Abstract. Author URL.
Magee LA, Wright D, Syngelaki A, von Dadelszen P, Akolekar R, Wright A, Nicolaides KH (2023). Preeclampsia Prevention by Timed Birth at Term. Hypertension, 80(5), 969-978. Abstract. Author URL.
Charakida M, Wright A, Magee LA, Syngelaki A, von Dadelszen P, Akolekar R, Wright D, Nicolaides KH (2023). Pregnancy—An Ideal Period to Identify Women at Risk for Chronic Hypertension. Hypertension, 81(2), 311-318.
von Dadelszen P, Syngelaki A, Wright A, Akolekar R, Magee LA, Wright D, Nicolaides KH (2023). The implications of the Fetal Medicine Foundation 35- to 36-week preeclampsia prediction competing-risk model on timing of birth. Am J Obstet Gynecol, 228(4), 457.e1-457.e7. Abstract. Author URL.
Kristensen SE, Kvist Ekelund C, Sandager P, Stener Jørgensen F, Hoseth E, Sperling L, Zingenberg HJ, Duelund Hjortshøj T, Gadsbøll K, Wright A, et al (2023). Triple trouble: uncovering the risks and benefits of early fetal reduction in trichorionic triplets in a large national Danish cohort study. Am J Obstet Gynecol, 229(5), 555.e1-555.e14. Abstract. Author URL.
Syngelaki A, Magee LA, von Dadelszen P, Akolekar R, Wright A, Wright D, Nicolaides KH (2022). Competing-risks model for pre-eclampsia and adverse pregnancy outcomes. Ultrasound Obstet Gynecol, 60(3), 367-372. Abstract. Author URL.
Gadsboll K, Wright A, Kristensen SE, Verfaille V, Nicolaides KH, Wright D, Petersen OB (2022). Crown-Rump Length Measurement Error: Impact on Assessment of Growth. OBSTETRICAL & GYNECOLOGICAL SURVEY, 77(3), 139-141. Author URL.
Kristensen SE, Ekelund CK, Sandager P, Joergensen FS, Hoseth E, Sperling L, Zingenberg HJ, Hjortshøj TD, Gadsbøll KM, Wright A, et al (2022). OC13.06:. Pregnancy outcome following fetal reduction of trichorionic triamniotic triplets: a national Danish register‐based study from 2008 to 2018. Ultrasound in Obstetrics and Gynecology, 60, 39-40.
Kristensen SE, Ekelund CK, Sandager P, Joergensen FS, Hoseth E, Sperling L, Zingenberg HJ, Hjortshøj TD, Gadsbøll KM, Wright A, et al (2022). OC13.09: Pregnancy outcome after fetal reduction of dichorionic triamniotic triplets: a national Danish register‐based study from 2008 to 2018. Ultrasound in Obstetrics and Gynecology, 60, 41-42.
Riishede I, Rode L, Sandager P, Wagner S, Pihl K, Joergensen FS, Zingenberg HJ, Nørgaard P, Sperling L, Overgaard M, et al (2022). OC14.01:. Pre‐eclampsia screening in Denmark (PRESIDE): a national implementation study. Ultrasound in Obstetrics and Gynecology, 60, 43-43.
Kristensen SE, Ekelund CK, Sandager P, Jørgensen FS, Hoseth E, Sperling L, Balaganeshan SB, Hjortshøj TD, Gadsbøll K, Wright A, et al (2022). Risks and pregnancy outcome after fetal reduction in dichorionic twin pregnancies: a Danish national retrospective cohort study. American Journal of Obstetrics and Gynecology, 228(5), 590.e1-590.e12.
Döbert M, Wright A, Varouxaki AN, Mu AC, Syngelaki A, Rehal A, Delgado JL, Akolekar R, Muscettola G, Janga D, et al (2022). STATIN trial: predictive performance of competing-risks model in screening for pre-eclampsia at 35-37 weeks' gestation. Ultrasound Obstet Gynecol, 59(1), 69-75. Abstract. Author URL.
Wright D, Tan MY, O'Gorman N, Syngelaki A, Nicolaides KH (2022). Serum PlGF compared with PAPP-A in first trimester screening for preterm pre-eclampsia: Adjusting for the effect of aspirin treatment. BJOG, 129(8), 1308-1317. Abstract. Author URL.
Wright D, Wright A, Tan MY, Nicolaides KH (2022). When to give aspirin to prevent preeclampsia: application of Bayesian decision theory. American Journal of Obstetrics and Gynecology, 226(2), S1120-S1125. Abstract.
Wright D, Nicolaides KH (2021). Competing risks model for prediction of preeclampsia. Am J Obstet Gynecol, 225(2), 205-206. Author URL.
Papastefanou I, Nowacka U, Syngelaki A, Mansukhani T, Karamanis G, Wright D, Nicolaides KH (2021). Competing risks model for prediction of small-for-gestational-age neonates from biophysical markers at 19 to 24 weeks' gestation. Am J Obstet Gynecol, 225(5), 530.e1-530.e19. Abstract. Author URL.
Papastefanou I, Wright D, Syngelaki A, Souretis K, Chrysanthopoulou E, Nicolaides KH (2021). Competing-risks model for prediction of small-for-gestational-age neonate from biophysical and biochemical markers at 11-13 weeks' gestation. Ultrasound Obstet Gynecol, 57(1), 52-61. Abstract. Author URL.
Papastefanou I, Nowacka U, Syngelaki A, Dragoi V, Karamanis G, Wright D, Nicolaides KH (2021). Competing-risks model for prediction of small-for-gestational-age neonate from estimated fetal weight at 19-24 weeks' gestation. Ultrasound Obstet Gynecol, 57(6), 917-924. Abstract. Author URL.
Papastefanou I, Wright D, Lolos M, Anampousi K, Mamalis M, Nicolaides KH (2021). Competing-risks model for prediction of small-for-gestational-age neonate from maternal characteristics, serum pregnancy-associated plasma protein-A and placental growth factor at 11-13 weeks' gestation. Ultrasound Obstet Gynecol, 57(3), 392-400. Abstract. Author URL.
Gadsbøll K, Wright A, Kristensen SE, Verfaille V, Nicolaides KH, Wright D, Petersen OB (2021). Crown-rump length measurement error: impact on assessment of growth. Ultrasound Obstet Gynecol, 58(3), 354-359. Abstract. Author URL.
Rehal A, Benkő Z, De Paco Matallana C, Syngelaki A, Janga D, Cicero S, Akolekar R, Singh M, Chaveeva P, Burgos J, et al (2021). Early vaginal progesterone versus placebo in twin pregnancies for the prevention of spontaneous preterm birth: a randomized, double-blind trial. Am J Obstet Gynecol, 224(1), 86.e1-86.e19. Abstract. Author URL.
Papastefanou I, Nowacka U, Buerger O, Akolekar R, Wright D, Nicolaides KH (2021). Evaluation of the RCOG guideline for the prediction of neonates that are small for gestational age and comparison with the competing risks model. BJOG, 128(13), 2110-2115. Abstract. Author URL.
Wright D, Nicolaides KH (2021). High dose progesterone for prevention of preterm birth in twins. Am J Obstet Gynecol, 224(5), 552-553. Author URL.
Döbert M, Varouxaki AN, Mu AC, Syngelaki A, Ciobanu A, Akolekar R, De Paco Matallana C, Cicero S, Greco E, Singh M, et al (2021). Pravastatin Versus Placebo in Pregnancies at High Risk of Term Preeclampsia. Circulation, 144(9), 670-679. Abstract. Author URL.
Wright D, Nicolaides K (2021). Re: Implementation of routine first trimester combined screening for pre-eclampsia: a clinical effectiveness study. BJOG, 128(1), 141-142. Author URL.
Wright A, Wright D, Nicolaides KH (2021). Reply. Ultrasound Obstet Gynecol, 57(2), 350-351. Author URL.
Johnson JM, Walsh J, Wright A, Wright D, Pastuck M, Loeffler J, Chadha R, Dwinnell S, Kuret V, Mahallati H, et al (2021). VP42.04: the feasibility of implementation of pre‐eclampsia screening and prevention. Ultrasound in Obstetrics and Gynecology, 58(S1), 272-272.
Bujold E, Audibert F, Johnson JM, Okun N, Chaillet N, Giguere Y, Forest J, Masse B, Wright D, Guerby P, et al (2021). VP42.07: First trimester prediction of preterm pre‐eclampsia using the Fetal Medicine Foundation algorithm. Ultrasound in Obstetrics and Gynecology, 58(S1), 273-273.
Papastefanou I, Wright D, Nicolaides KH (2020). Competing-risks model for prediction of small-for-gestational-age neonate from maternal characteristics and medical history. Ultrasound Obstet Gynecol, 56(2), 196-205. Abstract. Author URL.
Papastefanou I, Wright D, Syngelaki A, Lolos M, Anampousi K, Nicolaides KH (2020). Competing-risks model for prediction of small-for-gestational-age neonate from maternal characteristics and serum pregnancy-associated plasma protein-A at 11-13 weeks' gestation. Ultrasound Obstet Gynecol, 56(4), 541-548. Abstract. Author URL.
Chaveeva P, Wright A, Syngelaki A, Konstantinidou L, Wright D, Nicolaides KH (2020). First-trimester screening for trisomies in pregnancies with vanishing twin. Ultrasound Obstet Gynecol, 55(3), 326-331. Abstract. Author URL.
Wright D, Wright A, Smith E, Nicolaides KH (2020). Impact of biometric measurement error on identification of small- and large-for-gestational-age fetuses. Ultrasound Obstet Gynecol, 55(2), 170-176. Abstract. Author URL.
Khan N, Andrade W, De Castro H, Wright A, Wright D, Nicolaides KH (2020). Impact of new definitions of pre-eclampsia on incidence and performance of first-trimester screening. Ultrasound Obstet Gynecol, 55(1), 50-57. Abstract. Author URL.
Poon LC, Wright D, Thornton S, Akolekar R, Brocklehurst P, Nicolaides KH (2020). Mini-combined test compared with NICE guidelines for early risk-assessment for pre-eclampsia: the SPREE diagnostic accuracy study. Efficacy and Mechanism Evaluation, 7(8), 1-156.
Wright D, Wright A, Nicolaides KH (2020). The competing risk approach for prediction of preeclampsia. Am J Obstet Gynecol, 223(1), 12-23.e7. Abstract. Author URL.
Kristensen SE, Ekelund CK, Sandager P, Jørgensen FS, Hoseth E, Sperling L, Balaganeshan SB, Hjortshøj TD, Wright A, Wright D, et al (2020). VP22.14: National cohort study on fetal reduction in dichorionic twin pregnancies: risks and pregnancy outcome. Ultrasound in Obstetrics and Gynecology, 56(S1), 152-153.
Riishede I, Wright A, Wright D, Nørgaard P, Pihl K, Sandager P, Sperling L, Zingenberg HJ, Ekelund CK, Rode L, et al (2020). VP50.01: Quality assessment of first trimester uterine artery pulsatility index measurements in a pre‐eclampsia screening validation study. Ultrasound in Obstetrics and Gynecology, 56(S1), 284-285.
Wright D, Nicolaides KH (2019). Aspirin delays the development of preeclampsia. Am J Obstet Gynecol, 220(6), 580.e1-580.e6. Abstract. Author URL.
Wright D, Rolnik DL, Syngelaki A, de Paco Matallana C, Machuca M, de Alvarado M, Mastrodima S, Tan MY, Shearing S, Persico N, et al (2019). Aspirin for Evidence-based Preeclampsia Prevention Trial: Effect of Aspirin on Length of Stay in the Neonatal Intensive Care Unit. Obstetric Anesthesia Digest, 39(1), 40-41.
Ciobanu A, Wright A, Syngelaki A, Wright D, Akolekar R, Nicolaides KH (2019). Fetal Medicine Foundation reference ranges for umbilical artery and middle cerebral artery pulsatility index and cerebroplacental ratio. Ultrasound Obstet Gynecol, 53(4), 465-472. Abstract. Author URL.
Ciobanu A, Wright A, Panaitescu A, Syngelaki A, Wright D, Nicolaides KH (2019). Prediction of imminent preeclampsia at 35-37 weeks gestation. Am J Obstet Gynecol, 220(6), 584.e1-584.e11. Abstract. Author URL.
Wright D, Tan MY, O'Gorman N, Poon LC, Syngelaki A, Wright A, Nicolaides KH (2019). Predictive performance of the competing risk model in screening for preeclampsia. Am J Obstet Gynecol, 220(2), 199.e1-199.e13. Abstract. Author URL.
Nicolaides KH, Wright D (2019). Re: Prediction of pre-eclampsia: review of reviews. Ultrasound Obstet Gynecol, 54(4), 564-565. Author URL.
Wright D, Nicolaides KH (2019). Reply. Am J Obstet Gynecol, 221(5), 534-535. Author URL.
Benkő Z, Chaveeva P, de Paco Matallana C, Zingler E, Wright D, Nicolaides KH (2019). Revised competing-risks model in screening for pre-eclampsia in twin pregnancy by maternal characteristics and medical history. Ultrasound Obstet Gynecol, 54(5), 617-624. Abstract. Author URL.
Wright A, Wright D, Syngelaki A, Georgantis A, Nicolaides KH (2019). Two-stage screening for preterm preeclampsia at 11-13 weeks' gestation. Am J Obstet Gynecol, 220(2), 197.e1-197.e11. Abstract. Author URL.
Benkő Z, Chaveeva P, de Paco Matallana C, Zingler E, Wright A, Wright D, Nicolaides KH (2019). Validation of competing-risks model in screening for pre-eclampsia in twin pregnancy by maternal factors. Ultrasound Obstet Gynecol, 53(5), 649-654. Abstract. Author URL.
Poon LC, Rolnik DL, Tan MY, Delgado JL, Tsokaki T, Akolekar R, Singh M, Andrade W, Edeturk T, Jani JC, et al (2018). ASPRE Trial. Obstetrical & Gynecological Survey, 73(11), 623-625.
Poon LC, Rolnik DL, Tan MY, Delgado JL, Tsokaki T, Akolekar R, Singh M, Andrade W, Efeturk T, Jani JC, et al (2018). ASPRE trial: incidence of preterm pre-eclampsia in patients fulfilling ACOG and NICE criteria according to risk by FMF algorithm. Ultrasound Obstet Gynecol, 51(6), 738-742. Abstract. Author URL.
Rolnik DL, Wright D, Poon LC, O'Gorman N, Syngelaki A, de Paco Matallana C, Akolekar R, Cicero S, Janga D, Singh M, et al (2018). Aspirin Versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia. OBSTETRICAL & GYNECOLOGICAL SURVEY, 73(1), 11-12. Author URL.
Rolnik DL, Wright D, Poon LC, O’Gorman N, Syngelaki A, de Paco Matallana C, Akolekar R, Cicero S, Janga D, Singh M, et al (2018). Aspirin Versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia. Obstetric Anesthesia Digest, 38(1), 20-21.
Wright D, Rolnik DL, Syngelaki A, de Paco Matallana C, Machuca M, de Alvarado M, Mastrodima S, Tan MY, Shearing S, Persico N, et al (2018). Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin on length of stay in the neonatal intensive care unit. Am J Obstet Gynecol, 218(6), 612.e1-612.e6. Abstract. Author URL.
Tan MY, Wright D, Syngelaki A, Akolekar R, Cicero S, Janga D, Singh M, Greco E, Wright A, Maclagan K, et al (2018). Comparison of diagnostic accuracy of early screening for pre-eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE. Ultrasound Obstet Gynecol, 51(6), 743-750. Abstract. Author URL.
Nicolaides KH, Wright D, Syngelaki A, Wright A, Akolekar R (2018). Fetal Medicine Foundation fetal and neonatal population weight charts. Ultrasound Obstet Gynecol, 52(1), 44-51. Abstract. Author URL.
Litwinska M, Syngelaki A, Wright A, Wright D, Nicolaides KH (2018). Management of pregnancies after combined screening for pre-eclampsia at 19-24 weeks' gestation. Ultrasound Obstet Gynecol, 52(3), 365-372. Abstract. Author URL.
Poon L, Rolnik D, Tan M, Delgado J, Tsokaki T, Akolekar R, Singh M, Andrade W, Efeturk T, Jani J, et al (2018). OC10.01: ASPRE trial: incidence of preterm pre‐eclampsia in patients fulfilling ACOG and NICE criteria according to risk by the FMF algorithm. Ultrasound in Obstetrics and Gynecology, 52(S1), 21-21.
Tan MY, Poon LC, Rolnik DL, Syngelaki A, de Paco Matallana C, Akolekar R, Cicero S, Janga D, Singh M, Molina FS, et al (2018). Prediction and prevention of small-for-gestational-age neonates: evidence from SPREE and ASPRE. Ultrasound Obstet Gynecol, 52(1), 52-59. Abstract. Author URL.
Lind Malte A, Uldbjerg N, Wright D, Tørring N (2018). Prediction of severe pre-eclampsia/HELLP syndrome by combination of sFlt-1, CT-pro-ET-1 and blood pressure: exploratory study. Ultrasound Obstet Gynecol, 51(6), 768-774. Abstract. Author URL.
Panaitescu A, Ciobanu A, Syngelaki A, Wright A, Wright D, Nicolaides KH (2018). Screening for pre-eclampsia at 35-37 weeks' gestation. Ultrasound Obstet Gynecol, 52(4), 501-506. Abstract. Author URL.
Tan MY, Syngelaki A, Poon LC, Rolnik DL, O'Gorman N, Delgado JL, Akolekar R, Konstantinidou L, Tsavdaridou M, Galeva S, et al (2018). Screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation. Ultrasound Obstet Gynecol, 52(2), 186-195. Abstract. Author URL.
Rolnik DL, Wright D, Poon LCY, Syngelaki A, O'Gorman N, de Paco Matallana C, Akolekar R, Cicero S, Janga D, Singh M, et al (2017). ASPRE trial: performance of screening for preterm pre-eclampsia. Ultrasound Obstet Gynecol, 50(4), 492-495. Abstract. Author URL.
Santorum M, Wright D, Syngelaki A, Karagioti N, Nicolaides KH (2017). Accuracy of First-Trimester Combined Test in Screening for Trisomies 21, 18 and 13. Obstetrical & Gynecological Survey, 72(11), 631-632.
O'Gorman N, Wright D, Poon LC, Rolnik DL, Syngelaki A, Wright A, Akolekar R, Cicero S, Janga D, Jani J, et al (2017). Accuracy of competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation. Ultrasound Obstet Gynecol, 49(6), 751-755. Abstract. Author URL.
Santorum M, Wright D, Syngelaki A, Karagioti N, Nicolaides KH (2017). Accuracy of first-trimester combined test in screening for trisomies 21, 18 and 13. Ultrasound Obstet Gynecol, 49(6), 714-720. Abstract. Author URL.
Poon LC, Wright D, Rolnik DL, Syngelaki A, Delgado JL, Tsokaki T, Leipold G, Akolekar R, Shearing S, De Stefani L, et al (2017). Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history. Am J Obstet Gynecol, 217(5), 585.e1-585.e5. Abstract. Author URL.
Wright D, Poon LC, Rolnik DL, Syngelaki A, Delgado JL, Vojtassakova D, de Alvarado M, Kapeti E, Rehal A, Pazos A, et al (2017). Aspirin for Evidence-Based Preeclampsia Prevention trial: influence of compliance on beneficial effect of aspirin in prevention of preterm preeclampsia. Am J Obstet Gynecol, 217(6), 685.e1-685.e5. Abstract. Author URL.
Rolnik DL, Wright D, Poon LC, O’Gorman N, Syngelaki A, de Paco Matallana C, Akolekar R, Cicero S, Janga D, Singh M, et al (2017). Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia. New England Journal of Medicine, 377(7), 613-622.
Tan MY, Wright D, Koutoulas L, Akolekar R, Nicolaides KH (2017). Comparison of screening for pre-eclampsia at 31-34 weeks' gestation by sFlt-1/PlGF ratio and a method combining maternal factors with sFlt-1 and PlGF. Ultrasound Obstet Gynecol, 49(2), 201-208. Abstract. Author URL.
Francisco C, Wright D, Benkő Z, Syngelaki A, Nicolaides KH (2017). Competing-risks model in screening for pre-eclampsia in twin pregnancy according to maternal factors and biomarkers at 11-13 weeks' gestation. Ultrasound Obstet Gynecol, 50(5), 589-595. Abstract. Author URL.
Francisco C, Wright D, Benkő Z, Syngelaki A, Nicolaides KH (2017). Competing-risks model in screening for pre-eclampsia in twin pregnancy by maternal characteristics and medical history. Ultrasound Obstet Gynecol, 50(4), 501-506. Abstract. Author URL.
Dragan I, Wright D, Fiolna M, Leipold G, Nicolaides KH (2017). Development of pre-eclampsia within 4 weeks of sFlt-1/PlGF ratio > 38: comparison of performance at 31-34 vs 35-37 weeks' gestation. Ultrasound Obstet Gynecol, 49(2), 209-212. Abstract. Author URL.
Francisco C, Wright D, Benkő Z, Syngelaki A, Nicolaides KH (2017). Hidden high rate of pre-eclampsia in twin compared with singleton pregnancy. Ultrasound Obstet Gynecol, 50(1), 88-92. Abstract. Author URL.
O'Gorman N, Wright D, Poon LC, Rolnik DL, Syngelaki A, de Alvarado M, Carbone IF, Dutemeyer V, Fiolna M, Frick A, et al (2017). Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation: comparison with NICE guidelines and ACOG recommendations. Ultrasound Obstet Gynecol, 49(6), 756-760. Abstract. Author URL.
Rolnik D, Wright D, Poon L, O'Gorman N, Syngelaki A, de Paco Matallana C, Akolekar R, Cicero S, Janga D, Singh M, et al (2017). OC01.04: Aspirin versus placebo in pregnancies at high‐risk of preterm pre‐eclampsia: a multicentre, double‐blind, placebo‐controlled trial. Ultrasound in Obstetrics and Gynecology, 50(S1), 2-2.
O'Gorman N, Wright D, Poon L, Rolnik DL, Syngelaki A, De Alvarado M, Carbone F, Dutemeyer V, Fiolna M, Frick A, et al (2017). OC07.02: Multicentre screening for pre‐eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation: comparison to NICE guidelines and ACOG recommendations. Ultrasound in Obstetrics and Gynecology, 50(S1), 13-13.
Litwinska M, Wright D, Efeturk T, Ceccacci I, Nicolaides KH (2017). Proposed clinical management of pregnancies after combined screening for pre-eclampsia at 19-24 weeks' gestation. Ultrasound Obstet Gynecol, 50(3), 367-372. Abstract. Author URL.
Wright D, Dragan I, Syngelaki A, Akolekar R, Nicolaides KH (2017). Proposed clinical management of pregnancies after combined screening for pre-eclampsia at 30-34 weeks' gestation. Ultrasound Obstet Gynecol, 49(2), 194-200. Abstract. Author URL.
Panaitescu AM, Wright D, Militello A, Akolekar R, Nicolaides KH (2017). Proposed clinical management of pregnancies after combined screening for pre-eclampsia at 35-37 weeks' gestation. Ultrasound Obstet Gynecol, 50(3), 383-387. Abstract. Author URL.
Tan MY, Koutoulas L, Wright D, Nicolaides KH, Poon LCY (2017). Protocol for the prospective validation study: 'Screening programme for pre-eclampsia' (SPREE). Ultrasound Obstet Gynecol, 50(2), 175-179. Abstract. Author URL.
Andrietti S, Carlucci S, Wright A, Wright D, Nicolaides KH (2017). Repeat measurements of uterine artery pulsatility index, mean arterial pressure and serum placental growth factor at 12, 22 and 32 weeks in prediction of pre-eclampsia. Ultrasound Obstet Gynecol, 50(2), 221-227. Abstract. Author URL.
O'Gorman N, Wright D, Syngelaki A, Akolekar R, Wright A, Poon LC, Nicolaides KH (2016). Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation. Am J Obstet Gynecol, 214(1), 103.e1-103.e12. Abstract. Author URL.
Gallo DM, Wright D, Casanova C, Campanero M, Nicolaides KH (2016). Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 19-24 weeks' gestation. Am J Obstet Gynecol, 214(5), 619.e1-619.e17. Abstract. Author URL.
Tsiakkas A, Saiid Y, Wright A, Wright D, Nicolaides KH (2016). Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 30-34 weeks' gestation. Am J Obstet Gynecol, 215(1), 87.e1-87.e17. Abstract. Author URL.
Andrietti S, Silva M, Wright A, Wright D, Nicolaides KH (2016). Competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 35-37 weeks' gestation. Ultrasound Obstet Gynecol, 48(1), 72-79. Abstract. Author URL.
Wright D, Gallo DM, Gil Pugliese S, Casanova C, Nicolaides KH (2016). Contingent screening for preterm pre-eclampsia. Ultrasound Obstet Gynecol, 47(5), 554-559. Abstract. Author URL.
Wright A, Guerra L, Pellegrino M, Wright D, Nicolaides KH (2016). Maternal serum PAPP-A and free β-hCG at 12, 22 and 32 weeks' gestation in screening for pre-eclampsia. Ultrasound Obstet Gynecol, 47(6), 762-767. Abstract. Author URL.
Bredaki FE, Matalliotakis M, Wright A, Wright D, Nicolaides KH (2016). Maternal serum alpha-fetoprotein at 12, 22 and 32 weeks' gestation in screening for pre-eclampsia. Ultrasound Obstet Gynecol, 47(4), 466-471. Abstract. Author URL.
Tsiakkas A, Cazacu R, Wright A, Wright D, Nicolaides KH (2016). Maternal serum placental growth factor at 12, 22, 32 and 36 weeks' gestation in screening for pre-eclampsia. Ultrasound Obstet Gynecol, 47(4), 472-477. Abstract. Author URL.
Tsiakkas A, Mendez O, Wright A, Wright D, Nicolaides KH (2016). Maternal serum soluble fms-like tyrosine kinase-1 at 12, 22, 32 and 36 weeks' gestation in screening for pre-eclampsia. Ultrasound Obstet Gynecol, 47(4), 478-483. Abstract. Author URL.
Wright D, Krajewska K, Bogdanova A, Wright A, Nicolaides KH (2016). Maternal serum soluble fms-like tyrosine kinase-1 at 22 and 32 weeks in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol, 47(6), 755-761. Abstract. Author URL.
Tayyar A, Krithinakis K, Wright A, Wright D, Nicolaides KH (2016). Mean arterial pressure at 12, 22, 32 and 36 weeks' gestation in screening for pre-eclampsia. Ultrasound Obstet Gynecol, 47(5), 573-579. Abstract. Author URL.
Irvine SH, Wright DE, Recchia GG, De Carli G (2016). Measuring Quality of Life across Cultures: Some Cautions and Prescriptions. Therapeutic Innovation & Regulatory Science, 28(1), 55-62.
Irvine SH, Wright DE (2016). Psychological Aspects of Quality of Life in Asthma Patients: Measurement and Methods in Clinical Trials. Therapeutic Innovation & Regulatory Science, 28(1), 27-37.
O'Gorman N, Wright D, Rolnik DL, Nicolaides KH, Poon LC (2016). Study protocol for the randomised controlled trial: combined multimarker screening and randomised patient treatment with ASpirin for evidence-based PREeclampsia prevention (ASPRE). BMJ Open, 6(6). Abstract. Author URL.
Chitty LS, Wright D, Hill M, Verhoef TI, Daley R, Lewis C, Mason S, McKay F, Jenkins L, Howarth A, et al (2016). Uptake, Outcomes, and Costs of Implementing Non-invasive Prenatal Testing for Down Syndrome into NHS Maternity Care: Prospective Cohort Study in Eight Diverse Maternity Units EDITORIAL COMMENT. OBSTETRICAL & GYNECOLOGICAL SURVEY, 71(11), 637-639. Author URL.
Chitty LS, Wright D, Hill M, Verhoef TI, Daley R, Lewis C, Mason S, McKay F, Jenkins L, Howarth A, et al (2016). Uptake, outcomes, and costs of implementing non-invasive prenatal testing for Down's syndrome into NHS maternity care: prospective cohort study in eight diverse maternity units. BMJ, 354 Abstract. Author URL.
O'Gorman N, Tampakoudis G, Wright A, Wright D, Nicolaides KH (2016). Uterine artery pulsatility index at 12, 22, 32 and 36 weeks' gestation in screening for pre-eclampsia. Ultrasound Obstet Gynecol, 47(5), 565-572. Abstract. Author URL.
Wright D, Wright A, Nicolaides KH (2015). A unified approach to risk assessment for fetal aneuploidies. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 45(1), 48-54. Author URL.
Wright D, Syngelaki A, Akolekar R, Poon LC, Nicolaides KH (2015). Competing risks model in screening for preeclampsia by maternal characteristics and medical history. Am J Obstet Gynecol, 213(1), 62.e1-62.e10. Abstract. Author URL.
Akolekar R, Sarno L, Wright A, Wright D, Nicolaides KH (2015). Fetal middle cerebral artery and umbilical artery pulsatility index: effects of maternal characteristics and medical history. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 45(4), 402-408. Author URL.
Kagan K, Wright D, Nicolaides K (2015). First-trimester contingent screening for trisomies 21, 18 and 13 by fetal nuchal translucency and ductus venosus flow and maternal blood cell-free DNA testing. Ultraschall in der Medizin - European Journal of Ultrasound, 36(S 01).
Kagan KO, Wright D, Nicolaides KH (2015). First-trimester contingent screening for trisomies 21, 18 and 13 by fetal nuchal translucency and ductus venosus flow and maternal blood cell-free DNA testing. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 45(1), 42-47. Author URL.
Wright A, Wright D, Ispas CA, Poon LC, Nicolaides KH (2015). Mean arterial pressure in the three trimesters of pregnancy: effects of maternal characteristics and medical history. Ultrasound Obstet Gynecol, 45(6), 698-706. Abstract. Author URL.
Benn P, Borrell A, Chiu RWK, Cuckle H, Dugoff L, Faas B, Gross S, Huang T, Johnson J, Maymon R, et al (2015). Position statement from the Chromosome Abnormality Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis. PRENATAL DIAGNOSIS, 35(8), 725-734. Author URL.
Bredaki FE, Sciorio C, Wright A, Wright D, Nicolaides KH (2015). Serum alpha-fetoprotein in the three trimesters of pregnancy: effects of maternal characteristics and medical history. Ultrasound Obstet Gynecol, 46(1), 34-41. Abstract. Author URL.
Wright D, Papadopoulos S, Silva M, Wright A, Nicolaides KH (2015). Serum free β-human chorionic gonadotropin in the three trimesters of pregnancy: effects of maternal characteristics and medical history. Ultrasound Obstet Gynecol, 46(1), 51-59. Abstract. Author URL.
Tsiakkas A, Duvdevani N, Wright A, Wright D, Nicolaides KH (2015). Serum placental growth factor in the three trimesters of pregnancy: effects of maternal characteristics and medical history. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 45(5), 591-598. Author URL.
Wright D, Silva M, Papadopoulos S, Wright A, Nicolaides KH (2015). Serum pregnancy-associated plasma protein-A in the three trimesters of pregnancy: effects of maternal characteristics and medical history. Ultrasound Obstet Gynecol, 46(1), 42-50. Abstract. Author URL.
Tsiakkas A, Duvdevani N, Wright A, Wright D, Nicolaides KH (2015). Serum soluble fms-like tyrosine kinase-1 in the three trimesters of pregnancy: effects of maternal characteristics and medical history. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 45(5), 584-590. Author URL.
Ball S, Vickery J, Hobart J, Wright D, Green C, Shearer J, Nunn A, Cano MG, MacManus D, Miller D, et al (2015). The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis. Health Technol Assess, 19(12), vii-187. Abstract. Author URL.
Tayyar A, Guerra L, Wright A, Wright D, Nicolaides KH (2015). Uterine artery pulsatility index in the three trimesters of pregnancy: effects of maternal characteristics and medical history. Ultrasound Obstet Gynecol, 45(6), 689-697. Abstract. Author URL.
McGhee DJM, Ritchie CW, Thompson PA, Wright DE, Zajicek JP, Counsell CE (2014). A systematic review of biomarkers for disease progression in Alzheimer's disease. PLoS One, 9(2). Abstract. Author URL.
Tayyar A, Larroca SG-T, Poon LC, Wright D, Nicolaides KH (2014). Competing Risk Model in Screening for Preeclampsia by Mean Arterial Pressure and Uterine Artery Pulsatility Index at 30-33 Weeks' Gestation. FETAL DIAGNOSIS AND THERAPY, 36(1), 18-27. Author URL.
Larroca SG-T, Tayyar A, Poon LC, Wright D, Nicolaides KH (2014). Competing Risks Model in Screening for Preeclampsia by Biophysical and Biochemical Markers at 30-33 Weeks' Gestation. FETAL DIAGNOSIS AND THERAPY, 36(1), 9-17. Author URL.
Lai J, Larroca SG-T, Peeva G, Poon LC, Wright D, Nicolaides KH (2014). Competing Risks Model in Screening for Preeclampsia by Serum Placental Growth Factor and Soluble fms-Like Tyrosine Kinase-1 at 30-33 Weeks' Gestation. FETAL DIAGNOSIS AND THERAPY, 35(4), 240-248. Author URL.
Hill M, Wright D, Daley R, Lewis C, Mckay F, Mason S, Lench N, Howarth A, Boustred C, Lo K, et al (2014). Evaluation of non-invasive prenatal testing (NIPT) for aneuploidy in an NHS setting: a reliable accurate prenatal non-invasive diagnosis (RAPID) protocol. BMC PREGNANCY AND CHILDBIRTH, 14 Author URL.
Nicolaides KH, Syngelaki A, Poon LC, Gil MM, Wright D (2014). First-Trimester Contingent Screening for Trisomies 21, 18 and 13 by Biomarkers and Maternal Blood Cell-Free DNA Testing. FETAL DIAGNOSIS AND THERAPY, 35(3), 185-192. Author URL.
Nicolaides KH, Syngelaki A, Poon LC, Gil MM, Wright D (2014). First-Trimester Contingent Screening for Trisomies 21, 18, and 13 by Biomarkers and Maternal Blood Cell-Free DNA Testing. Obstetrical & Gynecological Survey, 69(9), 529-531.
Wright D, Syngelaki A, Bradbury I, Akolekar R, Nicolaides KH (2014). First-Trimester Screening for Trisomies 21, 18 and 13 by Ultrasound and Biochemical Testing. FETAL DIAGNOSIS AND THERAPY, 35(2), 118-126. Author URL.
Gallo D, Poon LC, Fernandez M, Wright D, Nicolaides KH (2014). Prediction of Preeclampsia by Mean Arterial Pressure at 11-13 and 20-24 Weeks' Gestation. FETAL DIAGNOSIS AND THERAPY, 36(1), 28-37. Author URL.
McGhee DJM, Royle PL, Thompson PA, Wright DE, Zajicek JP, Counsell CE (2013). A systematic review of biomarkers for disease progression in Parkinson's disease. BMC NEUROLOGY, 13 Author URL.
Norgaard P, Wright D, Ball S, Newell P, Kirkegaard I, Petersen OB, Uldbjerg N, Torring N, Jorgensen FS, Friis-Hansen L, et al (2013). Autocorrelation and cross-correlation between hCGβ and PAPP-A in repeated sampling during first trimester of pregnancy. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 51(9), 1781-1788. Author URL.
Akolekar R, Syngelaki A, Poon L, Wright D, Nicolaides KH (2013). Competing Risks Model in Early Screening for Preeclampsia by Biophysical and Biochemical Markers. FETAL DIAGNOSIS AND THERAPY, 33(1), 8-15. Author URL.
Zajicek J, Ball S, Wright D, Vickery J, Nunn A, Miller D, Cano MG, McManus D, Mallik S, Hobart J, et al (2013). Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial. Lancet Neurol, 12(9), 857-865. Abstract. Author URL.
Cowans NJ, Suonpaa M, Kouru H, Wright D, Spencer K (2013). Evaluation of a Dried Blood Spot Assay to Measure Prenatal Screening Markers Pregnancy-Associated Plasma Protein a and Free β-Subunit of Human Chorionic Gonadotropin. CLINICAL CHEMISTRY, 59(6), 968-975. Author URL.
Nicolaides KH, Wright D, Poon LC, Syngelaki A, Gil MM (2013). First-trimester contingent screening for trisomy 21 by biomarkers and maternal blood cell-free DNA testing. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 42(1), 41-50. Author URL.
Ekelund CK, Wulff CB, Ball S, Wright D, Tabor A (2013). OP17.06: First trimester biochemical markers in oocyte donated women. Ultrasound in Obstetrics and Gynecology, 42(s1), 96-97.
Benn P, Borell A, Chiu R, Cuckle H, Dugoff L, Faas B, Gross S, Johnson J, Maymon R, Norton M, et al (2013). Position statement from the Aneuploidy Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis. PRENATAL DIAGNOSIS, 33(7), 622-629. Author URL.
Benn P, Borrell A, Chiu R, Cuckle H, Dugoff L, Faas B, Gross S, Johnson J, Maymon R, Norton M, et al (2013). Response to "On gestational weeks and maths". PRENATAL DIAGNOSIS, 33(12), 1218-1219. Author URL.
Ball S, Ekelund C, Wright D, Kirkegaard I, Nørgaard P, Petersen OB, Tabor A, Danish Fetal Medicine Study Group (2013). Temporal effects of maternal and pregnancy characteristics on serum pregnancy-associated plasma protein-A and free β-human chorionic gonadotropin at 7-14 weeks' gestation. Ultrasound Obstet Gynecol, 41(1), 33-39. Abstract. Author URL.
Maiz N, Wright D, Ferreira AFA, Syngelaki A, Nicolaides KH (2012). A Mixture Model of Ductus Venosus Pulsatility Index in Screening for Aneuploidies at 11-13 Weeks' Gestation. FETAL DIAGNOSIS AND THERAPY, 31(4), 221-229. Author URL.
Wright D, Akolekar R, Syngelaki A, Poon LCY, Nicolaides KH (2012). A competing risks model in early screening for preeclampsia. Fetal Diagn Ther, 32(3), 171-178. Abstract. Author URL.
Kagan K, Yazdi B, Abele H, Wright D, Hoopmann M (2012). Einfluss von Messfehlern in der Scheitel-Steiß-Länge auf die Testgüte des Ersttrimester-Screenings. Ultraschall in der Medizin - European Journal of Ultrasound, 33(S 02).
Kagan KO, Hoopmann M, Baker A, Huebner M, Abele H, Wright D (2012). Impact of bias in crown-rump length measurement at first-trimester screening for trisomy 21. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 40(2), 135-139. Author URL.
Pandya P, Wright D, Syngelaki A, Akolekar R, Nicolaides KH (2012). Maternal Serum Placental Growth Factor in Prospective Screening for Aneuploidies at 8-13 Weeks' Gestation. FETAL DIAGNOSIS AND THERAPY, 31(2), 87-93. Author URL.
Chitty LS, Hill M, White H, Wright D, Morris S (2012). Noninvasive prenatal testing for aneuploidy-ready for prime time?. American Journal of Obstetrics and Gynecology, 206(4), 269-275.
Kirkegaard I, Ekelund CK, Ball S, Newell P, Wright D, Noergaard P, Soerensen S, Friis‐Hansen L, Toerring N, Uldbjerg N, et al (2012). OC15.03: Effects of gestational age at biochemical sampling on first‐trimester screening performance for trisomy 18 and 13. Ultrasound in Obstetrics and Gynecology, 40(S1), 31-31.
Newell P, Ball S, Wright D, Kirkegaard I, Uldbjerg N, Tørring N, Ekelund CK, Friis‐Hansen L, Nørgaard P, Sørensen S, et al (2012). OC15.04: Operator‐specific PAPP‐A and free beta‐hCG MoM values as a method of individual audit of CRL measurements at the NT scan. National data from 171,469 pregnancies. Ultrasound in Obstetrics and Gynecology, 40(S1), 31-31.
Kagan KO, Hoopmann M, Abele H, Yazdi B, Wright D (2012). OP07.04: Effect of bias in the CRL measurement on first trimester screening for trisomy 21. Ultrasound in Obstetrics and Gynecology, 40(S1), 76-76.
Ekelund CK, Wright D, Ball S, Kirkegaard I, Noergaard P, Joergensen FS, Soerensen S, Friis‐Hansen L, Toerring N, Bech BH, et al (2012). OP23.01: a prospective study evaluating the performance of first trimester combined screening for trisomy 21 using repeated sampling of the maternal serum markers PAPP‐A and free β‐hCG. Ultrasound in Obstetrics and Gynecology, 40(S1), 122-123.
Nørgaard P, Ball S, Newell P, Ekelund CK, Kirkegaard I, Uldbjerg N, Tørring N, Jørgensen F, Sørensen S, Friis‐Hansen L, et al (2012). OP23.06: Effects of method of conception and gestational age on first trimester biochemical markers. Ultrasound in Obstetrics and Gynecology, 40(S1), 124-124.
Benn P, Borrell A, Cuckle H, Dugoff L, Gross S, Johnson J-A, Maymon R, Odibo A, Schielen P, Spencer K, et al (2012). Prenatal Detection of Down Syndrome using Massively Parallel Sequencing (MPS): a rapid response statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, 24 October 2011. PRENATAL DIAGNOSIS, 32(1), 1-2. Author URL.
Ekelund C, Wright D, Ball S, Kirkegaard I, Norgaard P, Sorensen S, Friis-Hansen L, Jorgensen FS, Torring N, Bech BH, et al (2012). Prospective study evaluating performance of first-trimester combined screening for trisomy 21 using repeat sampling of maternal serum markers PAPP-A and free β-hCG. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 40(3), 276-281. Author URL.
Thompson PA, Wright DE, Counsell CE, Zajicek J (2012). Statistical analysis, trial design and duration in Alzheimer's disease clinical trials: a review. INTERNATIONAL PSYCHOGERIATRICS, 24(5), 689-697. Author URL.
Ball S, Wright D, Sodre D, Lachmann R, Nicolaides KH (2012). Temporal effect of Afro-Caribbean race on serum pregnancy-associated plasma protein-a at 9-13 weeks' gestation in screening for aneuploidies. Fetal Diagn Ther, 31(3), 162-169. Abstract. Author URL.
Hawton A, Green C, Telford CJ, Wright DE, Zajicek JP (2012). The use of multiple sclerosis condition-specific measures to inform health policy decision-making: mapping from the MSWS-12 to the EQ-5D. Mult Scler, 18(6), 853-861. Abstract. Author URL.
Hawton A, Green C, Telford C, Zajicek J, Wright D (2012). Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D. Value Health, 15(8), 1084-1091. Abstract. Author URL.
Madsen HN, Ball S, Wright D, Torring N, Petersen OB, Nicolaides KH, Spencer K (2011). A reassessment of biochemical marker distributions in trisomy 21-affected and unaffected twin pregnancies in the first trimester. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 37(1), 38-47. Author URL.
Benn P, Borrell A, Crossley J, Cuckle H, Dugoff L, Gross S, Johnson J-A, Maymon R, Odibo A, Schielen P, et al (2011). Aneuploidy screening: a position statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, January 2011. PRENATAL DIAGNOSIS, 31(6), 519-522. Author URL.
Turner S, Donalson K, Wright D, Baker A (2011). BECKMAN COULTER TOTAL HUMAN CHORIONIC GONADOTROPHIN (HCG) AND INHIBIN a IN SECOND TRIMESTER DOWN'S SCREENING USING a QUADRUPLE TEST: a RETROSPECTIVE COMPARISON WITH TRIPLE TESTING. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 49, S709-S709. Author URL.
Bredaki FE, Wright D, Matos P, Syngelaki A, Nicolaides KH (2011). First-Trimester Screening for Trisomy 21 Using Alpha-Fetoprotein. FETAL DIAGNOSIS AND THERAPY, 30(3), 215-218. Author URL.
Wright D, Syngelaki A, Birdir C, Bedei I, Nicolaides KH (2011). First-trimester screening for trisomy 21 with adjustment for biochemical results of previous pregnancies. Fetal Diagn Ther, 30(3), 194-202. Abstract. Author URL.
Wright D, Abele H, Baker A, Kagan KO (2011). Impact of bias in serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A multiples of the median levels on first-trimester screening for trisomy 21. Ultrasound Obstet Gynecol, 38(3), 309-313. Abstract. Author URL.
Kagan KO, Abele H, Yazdi B, Boeer B, Pintoffl K, Wright D, Hoopmann M (2011). Intraoperator and interoperator repeatability of manual and semi-automated measurement of increased fetal nuchal translucency according to the operator's experience. PRENATAL DIAGNOSIS, 31(13), 1229-1233. Author URL.
Bredaki FE, Wright D, Akolekar R, Cruz G, Nicolaides KH (2011). Maternal Serum Alpha-Fetoprotein in Normal Pregnancy at 11-13 Weeks' Gestation. FETAL DIAGNOSIS AND THERAPY, 30(4), 274-279. Author URL.
Karagiannis G, Akolekar R, Sarquis R, Wright D, Nicolaides KH (2011). Prediction of Small-for-Gestation Neonates from Biophysical and Biochemical Markers at 11-13 Weeks. FETAL DIAGNOSIS AND THERAPY, 29(2), 148-154. Author URL.
Wright D, Syngelaki A, Staboulidou I, Cruz JDJ, Nicolaides KH (2011). Screening for trisomies in dichorionic twins by measurement of fetal nuchal translucency thickness according to the mixture model. Prenat Diagn, 31(1), 16-21. Abstract. Author URL.
Wright D, Bradbury I, Malone F, D'Alton M, Summers A, Huang T, Ball S, Baker A, Nix B, Aitken D, et al (2010). Cross-trimester repeated measures testing for Down's syndrome screening: an assessment. Health Technol Assess, 14(33), 1-80. Abstract. Author URL.
Torring N, Ball S, Wright D, Sarkissian G, Guitton M, Darbouret B (2010). First trimester screening for trisomy 21 in gestational week 8-10 by ADAM12-S as a maternal serum marker. REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 8 Author URL.
Wright D, Spencer K, Kagan K K, Tørring N, Petersen OB, Christou A, Kallikas J, Nicolaides KH (2010). First-trimester combined screening for trisomy 21 at 7-14 weeks' gestation. Ultrasound Obstet Gynecol, 36(4), 404-411. Abstract. Author URL.
Abele H, Hoopmann M, Wright D, Hoffmann-Poell B, Huettelmaier M, Pintoffl K, Wallwiener D, Kagan KO (2010). Intra- and interoperator reliability of manual and semi-automated measurement of fetal nuchal translucency by sonographers with different levels of experience. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 36(4), 417-422. Author URL.
Zajicek JP, Ingram WM, Vickery J, Creanor S, Wright DE, Hobart JC (2010). Patient-orientated longitudinal study of multiple sclerosis in south west England (The South West Impact of Multiple Sclerosis Project, SWIMS) 1: protocol and baseline characteristics of cohort. BMC NEUROLOGY, 10 Author URL.
Moratalla J, Pintoffl K, Minekawa R, Lachmann R, Wright D, Nicolaides KH (2010). Semi-automated system for measurement of nuchal translucency thickness. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 36(4), 412-416. Author URL.
Imam I, Ball S, Wright D, Hanemann CO, Zajicek J (2010). The epidemiology of motor neurone disease in two counties in the southwest of England. JOURNAL OF NEUROLOGY, 257(6), 977-981. Author URL.
Kagan KO, Staboulidou I, Cruz J, Wright D, Nicolaides KH (2010). Two-stage first-trimester screening for trisomy 21 by ultrasound assessment and biochemical testing. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 36(5), 542-547. Author URL.
Alfirevic Z, Wright D (2009). Calculating patient-specific risk for Down syndrome: does software matter?. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 33(2), 133-134. Author URL.
Maiz N, Valencia C, Kagan KO, Wright D, Nicolaides KH (2009). Ductus venosus Doppler in screening for trisomies 21, 18 and 13 and Turner syndrome at 11-13 weeks of gestation. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 33(5), 512-517. Author URL.
Kagan KO, Wright D, Etchegaray A, Zhou Y, Nicolaides KH (2009). Effect of Deviation of Nuchal Translucency Measurements on the Performance of Screening for Trisomy 21 EDITORIAL COMMENT. OBSTETRICAL & GYNECOLOGICAL SURVEY, 64(10), 648-649. Author URL.
Kagan KO, Wright D, Etchegaray A, Zhou Y, Nicolaides KH (2009). Effect of deviation of nuchal translucency measurements on the performance of screening for trisomy 21. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 33(6), 657-664. Author URL.
Kagan KO, Cicero S, Staboulidou I, Wright D, Nicolaides KH (2009). Fetal nasal bone in screening for trisomies 21, 18 and 13 and Turner syndrome at 11-13 weeks of gestation. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 33(3), 259-264. Author URL.
Kagan KO, Wright D, Nicolaides K (2009). OP02.02: Effect of deviation of nuchal translucency measurements on the performance of screening for trisomy 21. Ultrasound in Obstetrics and Gynecology, 34(S1), 65-65.
Wright D, Kagan KO, Nicolaides K (2009). P11.12: Effect of deviation of free β‐hCG and PAPP‐A on the performance of screening for trisomy 21. Ultrasound in Obstetrics and Gynecology, 34(S1), 221-221.
Kagan KO, Etchegaray A, Zhou Y, Wright D, Nicolaides KH (2009). Prospective validation of first-trimester combined screening for trisomy 21. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 34(1), 14-18. Author URL.
Kagan KO, Valencia C, Livanos P, Wright D, Nicolaides KH (2009). Tricuspid regurgitation in screening for trisomies 21, 18 and 13 and Turner syndrome at 11+0 to 13+6 weeks of gestation. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 33(1), 18-22. Author URL.
Wright D, Kagan KO, Molina FS, Gazzoni A, Nicolaides KH (2008). A mixture model of nuchal translucency thickness in screening for chromosomal defects. Ultrasound Obstet Gynecol, 31(4), 376-383. Abstract. Author URL.
Kagan K, Maiz N, Wright D, Nicolaides K (2008). Contingent Screening auf Trisomie 21 mittels I. Trimester Combined Screening und dem Ductus venosus Fluss. Ultraschall in der Medizin - European Journal of Ultrasound, 29(S 03).
Cuckle HS, Malone FD, Wright D, Porter TF, Nyberg DA, Comstock CH, Saade GR, Berkowitz RL, Ferreira JC, Dugoff L, et al (2008). Contingent screening for Down syndrome. PRENATAL DIAGNOSIS, 28(8), 782-782. Author URL.
Cuckle HS, Malone FD, Wright D, Porter TF, Nyberg DA, Comstock CH, Saade GR, Berkowitz RL, Ferreira JC, Dugoff L, et al (2008). Contingent screening for Down syndrome - results from the FaSTER trial. PRENATAL DIAGNOSIS, 28(2), 89-94. Author URL.
Flanagan D, Moore E, Baker S, Wright D, Lynch P (2008). Diabetes care in hospital--the impact of a dedicated inpatient care team. Diabet Med, 25(2), 147-151. Abstract. Author URL.
Kagan KO, Wright D, Spencer K, Molina FS, Nicolaides KH (2008). First-Trimester Screening for Trisomy 21 by Free Beta-Human Chorionic Gonadotropin and Pregnancy-Associated Plasma Protein-A: Impact of Maternal and Pregnancy Characteristics. Obstetrical & Gynecological Survey, 63(9), 565-566.
Kagan KO, Wright D, Spencer K, Molina FS, Nicolaides KH (2008). First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 31(5), 493-502. Author URL.
Kagan K, Wright D, Nicolaides K (2008). Screening auf Trisomie 21, 18 und 13 mittels mütterlichem Alter, fetaler Nackentransparenz, fetaler Herzfrequenz, freiem ß-hCG und PAPP-A. Ultraschall in der Medizin - European Journal of Ultrasound, 29(S 03).
Kagan KO, Wright D, Valencia C, Maiz N, Nicolaides KH (2008). Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free β-hCG and pregnancy-associated plasma protein-A. HUMAN REPRODUCTION, 23(9), 1968-1975. Author URL.
Kagan KO, Wright D, Maiz N, Pandeva I, Nicolaides KH (2008). Screening for trisomy 18 by maternal age, fetal nuchal translucency, free β-human chorionic gonadotropin and pregnancy-associated plasma protein-A. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 32(4), 488-492. Author URL.
Kagan KO, Wright D, Baker A, Sahota D, Nicolaides KH (2008). Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 31(6), 618-624. Author URL.
Thompson Coon J, Rogers G, Hewson P, Wright D, Anderson R, Jackson S, Ryder S, Cramp M, Stein K (2008). Surveillance of cirrhosis for hepatocellular carcinoma: a cost-utility analysis. Br J Cancer, 98(7), 1166-1175. Abstract. Author URL.
Kagan KO, Wright D, Nicolaides KH (2008). The 1<SUP>st</SUP> trimester screening of Trisomie 21, 18 and 13 of maternal age, fetal NT and heart frequency, free beta HCC & PAPP-A. GEBURTSHILFE UND FRAUENHEILKUNDE, 68, S8-S8. Author URL.
Wright D, Spencer K, Nix B (2007). First trimester screening for Down syndrome using free beta hCG, total hCG and PAPP-A: an exploratory study. Prenat Diagn, 27(12), 1118-1122. Abstract. Author URL.
Coon JT, Rogers G, Hewson P, Wright D, Anderson R, Cramp M, Jackson S, Ryder S, Price A, Stein K, et al (2007). Surveillance of cirrhosis for hepatocellular carcinoma: Systematic review and economic analysis. Health Technology Assessment, 11(34). Abstract.
Thompson-Coon J, Hewson P, Rogers G, Wright D (2007). Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis.
Thompson Coon J, Rogers G, Hewson P, Wright D, Anderson R, Cramp M, Jackson S, Ryder S, Price A, Stein K, et al (2007). Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis. Health technology assessment (Winchester, England), 11(34), 1-206. Abstract.
Nix B, Wright D, Baker A (2007). The impact of bias in MoM values on patient risk and screening performance for Down syndrome. PRENATAL DIAGNOSIS, 27(9), 840-845. Author URL.
Knight B, Shields BM, Hill A, Powell RJ, Wright D, Hattersley AT (2007). The impact of maternal glycemia and obesity on early postnatal growth in a nondiabetic Caucasian population. Diabetes Care, 30(4), 777-783. Abstract. Author URL.
Manghat NE, Morgan-Hughes GJ, Broadley AJ, Undy MB, Wright D, Marshall AJ, Roobottom CA (2006). 16-detector row computed tomographic coronary angiography in patients undergoing evaluation for aortic valve replacement: comparison with catheter angiography. Clin Radiol, 61(9), 749-757. Abstract. Author URL.
Wright D, Bradbury I, Cuckle H, Gardosi J, Tonks A, Standing S, Benn P (2006). A matter of opinion or evidence!. PRENATAL DIAGNOSIS, 26(12), 1184-1184. Author URL.
Shields BM, Knight BA, Powell RJ, Hattersley AT, Wright DE (2006). Assessing newborn body composition using principal components analysis: differences in the determinants of fat and skeletal size. BMC Pediatr, 6 Abstract. Author URL.
Wright D, Bradbury I, Benn P, Nix B, Spencer K, Cuckle H (2006). CT ratios: Parameter estimates are inconsistent with SURUSS publications?. PRENATAL DIAGNOSIS, 26(10), 991-992. Author URL.
Stenhouse E, Wright DE, Hattersley AT, Millward BA (2006). Maternal glucose levels influence birthweight and 'catch-up' and 'catch-down' growth in a large contemporary cohort. Diabet Med, 23(11), 1207-1212. Abstract. Author URL.
Palomaki GE, Wright DE, Summers AM, Neveux LM, Meier C, O'Donnell A, Huang T, Knight GJ, Haddow JE (2006). Repeated measurement of pregnancy-associated plasma protein-A (PAPP-A) in Down syndrome screening: a validation study. PRENATAL DIAGNOSIS, 26(8), 730-739. Author URL.
Benn PA, Makowski GS, Egan JF, Wright D (2006). Reproducibility of Risk Figures in 2nd-Trimester Maternal Serum Screening for Down Syndrome: Comparison of 2 Laboratories. Clinical Chemistry, 52(11), 2087-2094.
Freeman RM, Adekanmi O, Waterfield MR, Waterfield AE, Wright D, Zajicek J (2006). The effect of cannabis on urge incontinence in patients with multiple sclerosis: a multicentre, randomised placebo-controlled trial (CAMS-LUTS). Int Urogynecol J Pelvic Floor Dysfunct, 17(6), 636-641. Abstract. Author URL.
Wright D, Bradbury I, Cuckle H, Gardosi J, Tonks A, Standing S, Benn P (2006). Three-stage contingent screening for Down syndrome. Prenat Diagn, 26(6), 528-534. Abstract. Author URL.
Zajicek JP, Sanders HP, Wright DE, Vickery PJ, Ingram WM, Reilly SM, Nunn AJ, Teare LJ, Fox PJ, Thompson AJ, et al (2005). Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up. J Neurol Neurosurg Psychiatry, 76(12), 1664-1669. Abstract. Author URL.
Ritchie K, Bradbury I, Slattery J, Wright D, Iqbal K, Penney G (2005). Economic modelling of antenatal screening and ultrasound scanning programmes for identification of fetal abnormalities. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 112(7), 866-874. Author URL.
Benn P, Wright D, Cuckle H (2005). Practical strategies in contingent sequential screening for Down syndrome. PRENATAL DIAGNOSIS, 25(8), 645-652. Author URL.
Wright DE, Bradbury I (2005). Repeated measures screening for Down's Syndrome. BJOG, 112(1), 80-83. Abstract. Author URL.
Wright D, Bradbury I, Benn P, Cuckle H, Ritchie K (2005). Which contingent sequential screening protocol?. PRENATAL DIAGNOSIS, 25(6), 520-521. Author URL.
Wright D, Bradbury I, Benn P, Cuckle H, Ritchie K (2005). Which contingent sequential screening protocol?: a response. PRENATAL DIAGNOSIS, 25(12), 1169-1170. Author URL.
Carroll CB, Bain PG, Teare L, Liu X, Joint C, Wroath C, Parkin SG, Fox P, Wright D, Hobart J, et al (2004). Cannabis for dyskinesia in Parkinson disease: a randomized double-blind crossover study. Neurology, 63(7), 1245-1250. Abstract. Author URL.
Allwood ACL, Madar RJ, Baumer JH, Readdy L, Wright D (2004). Changes in Resuscitation Practice at Birth. Obstetrical & Gynecological Survey, 59(3), 187-188.
Wright D, Bradbury I, Benn P, Cuckle H, Ritchie K (2004). Contingent screening for Down syndrome is an efficient alternative to non-disclosure sequential screening. Prenat Diagn, 24(10), 762-766. Abstract. Author URL.
Bradbury I, Wright D, Slattery J, Ritchie K (2004). Cost utility of prenatal diagnosis. LANCET, 363(9415), 1164-1165. Author URL.
Stenhouse E, Wright DE, Hattersley AT, Millward A (2004). The accuracy of birth weight. J Clin Nurs, 13(6), 767-768. Author URL.
Stenhouse E, Wright DE, Hattersley AT, Millward BA (2004). Weight differences in Plymouth toddlers compared to the British Growth Reference Population. Arch Dis Child, 89(9), 843-844. Abstract. Author URL.
Wright DE, Bray I (2003). A mixture model for rounded data. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES D-THE STATISTICIAN, 52, 3-13. Author URL.
Zajicek, Fox P, Sanders H, Wright D (2003). Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial . The Lancet, 362(9395), 1517-1526.
Allwood ACL, Madar RJ, Baumer JH, Readdy L, Wright D (2003). Changes in resuscitation practice at birth. Arch Dis Child Fetal Neonatal Ed, 88(5), F375-F379. Abstract. Author URL.
Stenhouse E, Wright D, Hattersley A, Millward A (2003). How well do midwives estimate the date of delivery?. Midwifery, 19(2), 125-131. Abstract. Author URL.
Stenhouse E, Wright DE, Hattersley AT, Millward BA (2002). Birth weight is an accurate and reliable measurement and can be used in studies of Type 1 and 2 diabetes. DIABETES, 51, A537-A537. Author URL.
Luyt K, Boyle B, Wright DE, Petros AJ (2002). Compared with specialist registrars, experienced staff nurses shorten the duration of weaning neonates from mechanical ventilation. Pediatric Critical Care Medicine, 3(4), 351-354.
Kingsnorth AN, Wright D, Porter CS, Robertson G (2002). Prolene Hernia System compared with Lichtenstein patch: a randomised double blind study of short-term and medium-term outcomes in primary inguinal hernia repair. Hernia, 6(3), 113-119. Abstract. Author URL.
Zhao HX, Mold MD, Stenhouse EA, Bird SC, Wright DE, Demaine AG, Millward BA (2001). Drinking water composition and childhood-onset Type 1 diabetes mellitus in Devon and Cornwall, England. DIABETIC MEDICINE, 18(9), 709-717. Author URL.
Luyt K, Wright D, Baumer JH (2001). Randomised study comparing extent of hypocarbia in preterm infants during conventional and patient triggered ventilation. Arch Dis Child Fetal Neonatal Ed, 84(1), F14-F17. Abstract. Author URL.
Challenor J, Wright D (2000). Aggression in boat builders: a search for altered mood states in boat builders exposed to styrene. Occup Med (Lond), 50(3), 185-192. Abstract. Author URL.
Wright DE, Bray I (2000). Estimating birth prevalence of Down's syndrome. J Epidemiol Biostat, 5(2), 89-97. Abstract. Author URL.
Hughes CH, Jones RCM, Wright DE, Dobbs FF (1999). A retrospective study of the relationship between childhood asthma and respiratory infection during gestation. CLINICAL AND EXPERIMENTAL ALLERGY, 29(10), 1378-1381. Author URL.
Jones RCM, Hughes CR, Wright D, Baumer JH (1999). Early house moves, indoor air, heating methods and asthma. RESPIRATORY MEDICINE, 93(12), 919-922. Author URL.
Bray I, Wright DE (1998). Application of Markov chain Monte Carlo methods to modelling birth prevalence of Down syndrome. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS, 47, 589-602. Author URL.
Bray IC, Wright DE (1998). Estimating the spontaneous loss of Down syndrome fetuses between the times of chorionic villus sampling, amniocentesis and livebirth. PRENATAL DIAGNOSIS, 18(10), 1045-1054. Author URL.
Bray I, Wright DE, Davies C, Hook EB (1998). Joint estimation of Down syndrome risk and ascertainment rates: a meta-analysis of nine published data sets. Prenat Diagn, 18(1), 9-20. Abstract. Author URL.
Luan JA, Stander J, Wright D (1998). On shape detection in noisy images with particular reference to ultrasonography. STATISTICS AND COMPUTING, 8(4), 377-389. Author URL.
Reynolds TM, Dunstan F, Nix B, Williams K, Crossley J, Holding S, Krantz D, Wright D, Bray I, Spencer K, et al (1998). Response to:: !Wald, N.J.!Hackshaw, A.K. (1997).: Combining ultrasound and biochemistry in first-trimester screening for Down's syndrome, <i>Prenat</i>. <i>Diagn</i>. 17, 821-829. PRENATAL DIAGNOSIS, 18(5), 511-515. Author URL.
Baumer JH, Wright D, Mill T (1997). Illness severity measured by CRIB score: a product of changes in perinatal care?. Arch Dis Child Fetal Neonatal Ed, 77(3), F211-F215. Abstract. Author URL.
Wright D, Stander J, Nicolaides K (1997). Nonparametric density estimation and discrimination from images of shapes. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS, 46(3), 365-380. Author URL.
Dennis I, Newstead SE, Wright DE (1996). A new approach to exploring biases in educational assessment. BRITISH JOURNAL OF PSYCHOLOGY, 87, 515-534. Author URL.
Wright D, Stander J (1996). S-Plus version 3.2, release 1 for Windows. BRITISH JOURNAL OF MATHEMATICAL & STATISTICAL PSYCHOLOGY, 49, 206-208. Author URL.
COLLIS JM, TAPSFIELD PGC, IRVINE SH, DANN PL, WRIGHT D (1995). THE BRITISH ARMY RECRUIT BATTERY GOES OPERATIONAL - FROM THEORY TO PRACTICE IN COMPUTER-BASED TESTING USING ITEM-GENERATION TECHNIQUES. INTERNATIONAL JOURNAL OF SELECTION AND ASSESSMENT, 3(2), 96-104. Author URL.
IRVINE SH, WRIGHT DE, DECARLI G, RECCHIA G (1994). LIMITS AND PARADOXES IN CROSS-NATIONAL QUALITY-OF-LIFE MEASUREMENT - STIMULUS IDENTITY OR ITEM EQUIVALENCE. QUALITY OF LIFE RESEARCH, 3(1), 81-81. Author URL.
DECARLI G, RECCHIA G, IRVINE SH, WRIGHT DE (1994). MEASURING QUALITY-OF-LIFE AMONG ASTHMA PATIENTS IN ITALY - ADAPTING FOR ADULTS, DEVELOPING FOR CHILDREN. QUALITY OF LIFE RESEARCH, 3(1), 73-73. Author URL.
Wright DE, Reynolds TM, Donovan CM (1993). Assessment of atypicality: an adjunct to prenatal screening for Down's syndrome that facilitates detection of other abnormalities. Ann Clin Biochem, 30 ( Pt 6), 578-583. Abstract. Author URL.
Irvine SH, Wright DE, Recchia G, De Carli G, Zanferrari G (1993). Quality of life measurement. Monaldi Arch Chest Dis, 48(5), 549-553. Author URL.
DELLAPORTAS P, WRIGHT DE (1991). NUMERICAL PREDICTION FOR THE 2-PARAMETER WEIBULL DISTRIBUTION. STATISTICIAN, 40(4), 365-372. Author URL.
WRIGHT DE, HAZELHURST CE (1988). ESTIMATION AND PREDICTION FOR a SIMPLE SOFTWARE-RELIABILITY MODEL. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES D-THE STATISTICIAN, 37(3), 319-325. Author URL.
IFEACHOR EC, JERVIS BW, ALLEN EM, MORRIS EL, WRIGHT DE, HUDSON NR (1988). INVESTIGATION AND COMPARISON OF SOME MODELS FOR REMOVING OCULAR ARTIFACTS FROM EEG SIGNALS. 1. REVIEW OF MODELS AND DATA-ANALYSIS. MEDICAL & BIOLOGICAL ENGINEERING & COMPUTING, 26(6), 584-590. Author URL.
IFEACHOR EC, JERVIS BW, ALLEN EM, MORRIS EL, WRIGHT DE, HUDSON NR (1988). INVESTIGATION AND COMPARISON OF SOME MODELS FOR REMOVING OCULAR ARTIFACTS FROM EEG SIGNALS. 2. QUANTITATIVE AND PICTORIAL COMPARISON OF MODELS. MEDICAL & BIOLOGICAL ENGINEERING & COMPUTING, 26(6), 591-598. Author URL.
WRIGHT DE (1986). A NOTE ON THE CONSTRUCTION OF HIGHEST POSTERIOR DENSITY INTERVALS. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS, 35(1), 49-53. Author URL.
BEAUMONT C, WRIGHT D (1986). DETRENDING EXPERT SYSTEMS IN STATISTICS. JOURNAL OF THE OPERATIONAL RESEARCH SOCIETY, 37(12), 1145-1145. Author URL.
DUNSMORE IR, WRIGHT DE (1985). A DECISIVE PREDICTIVE APPROACH TO THE CONSTRUCTION OF SEQUENTIAL ACCEPTANCE SAMPLING PLANS FOR LIFETIMES. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS, 34(1), 1-13. Author URL.
WRIGHT DE (1983). SEQUENTIAL BATCH ACCEPTANCE SAMPLING FOR EXPONENTIAL LIFETIMES. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES D-THE STATISTICIAN, 32(1-2), 127-130. Author URL.
Wright DE (1968). The differential leucocyte count of human saliva. Archives of Oral Biology, 13(9), 1159-1161.
Wright DE (1964). The source and rate of entry of leucocytes in the human mouth. Archives of Oral Biology, 9(3). Abstract.
Wright DE (1962). Leucocytes in the saliva of edentulous and caries-free subjects. Archives of Oral Biology, 7(5), 581-585. Abstract.
Wright DE, Jenkins GN (1953). An Observed Correlation Between Ammonia Concentration and Acid Production in Saliva. Journal of Dental Research, 32(2), 232-238.
JENKINS GN, WRIGHT DE (1953). Leucocytes in saliva. The Journal of physiology, 121(1).
Wright DE, Jenkins GN (1953). Leukocytes in the Saliva of Caries-Free and Caries-Active Subjects. Journal of Dental Research, 32(4), 511-523.
JENKINS GN, WRIGHT DE (1951). The role of ammonia in dental caries. Part II. Effect of ammonium salts and urea on salivary organisms. British dental journal, 90(5), 117-130.
Jenkins GN, Wright DE, Miller TK (1950). Ammonia and dental caries. Nature, 165(4198), 606-607. Abstract.
JENKINS GN, WRIGHT DE (1950). The role of salivary ammonia in dental caries. British dental journal, 89(12), 261-265.
Conferences
Khan N, Wright A, Syngelaki A, Wright D, Nicolaides K (2019). Competing risk model in screening for pre-eclampsia. Author URL.
Hornby ST, Ball S, Barrett L, Ayling R, Wright D, Sanders G, Wheatley TW (2014). Faecal and plasma biomarkers combined with Bayesian prior risk modelling as a screening test for oesophago-gastric cancer. Author URL.
Hawton AJ, Green C, Zajicek J, Wright D (2013). Health state (QALY) values for multiple sclerosis: Improving the quality of information used in cost-effectiveness analyses of treatments for MS. Author URL.
Hornby S, Ball S, Droog S, Wright D, Wheatley T, Sanders G (2013). Systematic review of risk factors for Oesophago-gastric cancer. Author URL.
Hornby S, Ball S, Barrett L, Ayling R, Wright D, Sanders G, Wheatley T (2013). The performance of faecal and plasma biomarkers with a Bayesian prior risk model as a potential screening programme for Oesophago-gastric cancer. Author URL.
Zajicek J, Hobart J, Wright D, Ball S, Nunn A, Vickery J (2012). RESULTS FROM THE CANNABINNOID USE IN PROGRESSIVE INFLAMMATORY BRAIN DISEASE (CUPID) TRIAL. Author URL.
Imam I, Ball S, Wright D, Hanemann O, Zajicek J (2009). THE EPIDEMIOLOGY OF MOTOR NEURONE DISEASE IN TWO COUNTIES IN THE SOUTH WEST OF ENGLAND. Author URL.
Wright DE, Bradbury I, Sanders HP, Vickery PJ, Zajicek JP (2006). CAMS revisited: an efficient Bayesian analysis of Ashworth and Rivermead data. Author URL.
Teare LJ, Zajicek JP, Wright D, Priston M (2006). Correlations between cannabinoid levels and the Ashworth Score Support results from the CAM trial. Author URL.
Warner M, Baron RA, Ingram WM, Vickery PJ, Reilly S, Wright DE, Zajicek JP, Hobart JC (2006). Does the GHQ-30 leave room for change?. Author URL.
Ingram WM, Hobart JC, Reilly SM, Vickery PJ, Wright DE, Zajicek JP (2006). Introducing the south west impact of multiple sclerosis (SWIMS) project: a population-based natural history project to acquire patient-orientated information about the impact of multiple sclerosis. Author URL.
Baron R, Ingram W, Warner M, Vickery PJ, Wright DE, Zajicek J, Hobart JC (2006). Meaningless statistics and the illusion of fatigue. Author URL.
Malone FO, Wright D, Cuckle H, Ball RH, Nyberg DA, Comstock CH, Saade GR, Berkowitz RL, Gross SJ, Dugoff L, et al (2006). Repeated measures screening for trisomy 21 - Results from a general population screening trial (the faster trial). Author URL.
Baron R, Zajicek J, Wright D, Vickery J, Ingram W, Reilly S, Hobart J (2005). Confounding the confused: is measuring the frequency and severity of cognitive impairment really necessary?. Author URL.
Baron R, Zajicek J, Wright D, Vickery J, Ingram W, Hobart J (2005). Confounding the confused: is measuring the frequency and severity of cognitive impairment really necessary?. Author URL.
Teare LJ, Zajicek JP, Wright D, Priston M (2005). Do blood levels explain clinical differences between whole extract of cannabis and pure delta-9-tetrahydrocannabinol in the treatment of multiple sclerosis symptoms?. Author URL.
Cuckle H, Benn P, Wright D (2005). Down syndrome screening in the first and/or second trimester: Model predicted performance using meta-analysis parameters. Author URL.
Ingram W, Hobart J, Reilly S, Vickery P, Wright D, Zajicek J (2005). Introducing the South West Impact of Multiple Sclerosis Project: a patient-focused natural history study of multiple sclerosis. Author URL.
Shields BM, Knight B, Hopper H, Hill A, Powell R, Hattersley AT, Wright D (2005). Maternal BMI not maternal glucose alters early childhood growth. Author URL.
Baron R, Ingram W, Warner M, Vickery J, Wright D, Zajicek J, Hobart J (2005). Meaningless statistics and the illusion of fatigue measurement. Author URL.
Teare LJ, Zajicek JR, Priston M, Wright D (2005). The relationship between cannabinoid levels and clinical effect in multiple sclerosis. Author URL.
Teare L, Vickery J, Fox P, Wright D, Sanders H, Thompson A, Zajicek J (2004). Cannabinoids in MS - Long-term results from the CAMS. Author URL.
Zajicek J, Fox R, Teare L, Sanders H, Wright D, Vickery J, Ingram W, Reilly S, Nunn A, Thompson A, et al (2004). Cannabinoids in multiple sclerosis (CAMS) study, follow-up data suggesting an effect on disease progression. Author URL.
Davies AF, Segar EP, Murdoch J, Wright DE, Wilson IH (2004). Epidural infusion or combined femoral and sciatic nerve blocks as perioperative analgesia for knee arthroplasty. Author URL.
Davies AF, Segar EP, Murdoch J, Wright D, Wilson IH (2003). Comparison of epidural analgesia with femoral (3 in 1)/sciatic nerve blocks for total knee arthroplasty. Author URL.
Allwood A, Madar J, Baumer H, Readdy L, Wright D (2003). Intubation at birth - What's the need?. Author URL.
Wright D (2002). Scoring tests when items have been generated. Author URL.
WRIGHT D, DAVIES C, DONOVAN C (1994). ESTIMATING THE UNCERTAINTY IN REPORTED DOWN-SYNDROME DETECTION RATES - APPLICATION OF MATHEMATICAL-MODELING TECHNIQUES TO THE TRIPLE TEST AND FREE BETA-INTACT HCG. Author URL.
